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Linker histones (H1, H1o H5, subtypes and variants) play a pivotal role
in formation of higher order chromatin structure and thus – as main regu-
lators of the expression of genetic information kept in DNA. That is why
the knowledge of the nature of linker histones/DNA interactions is of a
greatest interest in understanding of such important issues as transcription
regulation, cell division, and cancerogenesis. As DNA is a main “target” of
most anticancer antibiotics, the analysis of competitive reactions between
that drugs (in our case actinomycin D and netropsin) and linker histones
for binding to certain sites in DNA gives hopeful information concerning
the mode of such interactions. In this work we present statistical analysis
of some experimental data concerning the influence of some anticancer an-
tibiotics on linker histones/DNA interactions. First, it was investigated the
formulated hypothesis of the dependence of H1/DNA interaction on actino-
mycin D concentration. Such a relation was expected knowing the different
mode for binding of the both drugs to DNA double helix. The applied
statistical analysis using chi-square test for independence showed that the
concentration of Actinomycin D in reaction mixture had no essential effect
on linker histone/DNA binding. On the contrary, the same analysis with the
second antibiotic – netropsin showed that we could not reject the hypothesis
of dependence. Some other statistical models are also proposed, applying
χ
2 test for homogeneity, test of Willcockson, Smirnov’s test and others.
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1. Introduction
The organization of DNA in eukaryotes in compact structures (chromatin) is due
to the nuclear proteins including linker histones – H1, H1o, H5, and subtypes
(van Holde, 1987; Zlatanova, 1990; Zlatanova and Yaneva, 1991a; Jerzmanowski,
2004) demostrated in Fig.1.
Figure 1: Levels of DNA organization in eukaryotic cell: double helix → super helix →
nucleosomes → solenoid → chromosomes. The participation of linker histones (H1) in
formation of higher-level chromatin structure is obvious (according to Mattews and van
Holde, 1995).
The comprehensive data for position of linker histones in nucleosomes and in
the compact forms of nucleosomal filaments have been interpreted as indicative
of its critical function in chromatin architecture and dynamics and consequently
in the regulation of such fundamental processes as transcription and chromo-
some condensation (Zlatanova and Leuba, 2004). Recently Zlatanova, Caiafa
and van Holde (2000) reviewed the evidences for involvement of linker histones in
transcriptional regulation and proposed an original scenario according which the
reversible and controlable binding and displacement of these class proteins deter-
mine the accessibility of DNA from chromatin to the transcriptional machinery
and further processing. The way linker histones interact with DNA – major or
minor groove, sequential and conformational preferences, and the active parts of
Linker Histones/DNA Interactions 339
protein molecule – are the object of versatile investigations by many outstanding
laboratories (reviewed by Churchill and Travers, 1991; Zlatanova and Yaneva,
1991b; Zlatanova and van Holde, 1996; Mamoon et al., 2002). Competitive reac-
tions with some anticancer antibiotics throw light to the mode of linker histones/
DNA interactions, and also to the mechanism of action of these antibiotics, tar-
geting double-helix DNA molecule (Burckhardt et al., 1983; Copenhaver et al.,
1995; Wemmer, 1998; Yaneva et al., 2000). Due to the essential for realization of
genetic information interaction of DNA with regulatory proteins, during the past
decade a hypothesis for existence of “two additional channels of information in
DNA” arose – of major and minor groove (Lown, 1994)- see Fig. 2. The major
groove is exploited mainly by control function proteins – promoters, repressors,
enhancers; the minor groove is attacked by different enzymes, proteins with reg-
ulatory and architectural function and antibiotics, all known as minor-groove
binders – MGB (Brosh et al., 2000). Thus the minor groove seems to be much
vulnerable to attacks structure. This is considered to be an important reason for
evolution of antibiotics - to attack directly DNA of concurrent organism (Neidle
et al., 1987; Kahne, 1995; Jeeninga et al., 1998; Moravek et al., 2002).
Actinomycin D (Act. D) is a wide-spectrum antibiotic, naturally produced
by some species from Streptomyces genera. The drug structure has been inten-
sively investigated and determinated by means of chemical and physical methods
(reviewed by Neidle at al., 1987; Pullman, 1989; Bailly et al., 1994; Chow et al.,
2002; Hou et al., 2002). Its structure includes a flat phenoxazone ring and two
circle lactopeptones attached on both sides of the molecule Fig.3). In spite of
the fact that Act. D has been used as a successful anticancer drug since 1972,
its mechanism of action was elucidated only ten years ago (Bailly et al., 1994).
Recently the ”shuﬄing hypothesis” was proposed by Fox and Waring (1986). Ac-
cording to it the antibiotic molecule initially binds accidentally to certain regions
of DNA and its phenoxazone ring penetrates inside the double helix, intercalating
between two planar bases (preferentially GC). If it happened to be its ”favorite”
binding site, its two peptide lactones ”invade” into the minor groove from both
sides. Otherwise, the drug molecule moves along the DNA chain and ”shuﬄes”
finding the preferred site.
2. Experimental data on drug-competition assays and hypothe-
ses
Our work is based on a series of experiments of competitive reaction between
Act. D and linker histone H1 for binding to DNA double helix (drug-competition
assay). The existing experimental data concerning linker histones/DNA inter-
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Figure 2: Computer drawing of DNA double helix: the minor and the major grooves of
the polynucleotide chain might be clearly recognized (designated on right).
actions (with major or minor groove) are quite contradictory. We have studied
the association of H1 with DNA in competitive reactions with Act.D – as a
function of its final concentration in the reaction mixture. The main approach
in this research was the observation of the mobility changes of DNA molecule
(alone or complexes with proteins) in electric field – electromobility shift assay
(EMSA). As a DNA probe an isolated discrete fragment of 2073 base pairs from
plasmid pUC19 digested with restriction endonuclease Bst NI was used. It has
been incubated with histone H1 in the presence of increasing concentrations of
the antibiotic (the protein/DNA ratio was constant – about 2.0 w/w). In such a
reaction the antibiotic might has facilitating (F), inhibiting (I) or no effect (N) on
the histone/DNA complex formation. An important difference appears perform-
ing the experiment with preliminary incubation of the drug with DNA and then
consequent addition of histone to the incubation mixture. Correct interpretation
of experimental data is needed to build an adequate hypothesis about mechanism
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Figure 3: Structural formulae of anticancer antibiotics Actinomycin D and Netropsin
(according to Neidle et al., 1987).
of linker histones/DNA interactions, as well as making clear the action of some
drugs. We have formulated following assumptions as working hypotheses:
1. The preference of linker histones for binding to bent (kinked, curved) re-
gions of DNA is considered to be proved (Yaneva et al, 1995; Yaneva et
al., 1997). The conformational changes in DNA polynucleotide chain after
Act. D treatment (some kind of DNA bending provoked by penetrating of
peptide lactones of Act. D molecule into the minor groove) might provoke
a facilitation of protein/DNA interactions.
2. The invasion of peptide lactones from the antibiotic molecule into DNA
minor groove could arouse spatial extension of major groove and facilitation
of linker histones binding to DNA.
3. Statistical analysis of antibiotic influence on linker histone/
DNA interaction
We can summarize the results of our experiments in the following Table 1, where
the columns represent the possible three different effects of the antibiotic and the
rows – different molar concentration of Act. D in the incubation mixture during
the drug-competition assay.
That sort of data is naturally investigated by means of chi-square analyze.
We used Matlab to complete the computations. The results we obtained lead to
the following conclusions:
1. We can accept the hypothesis of independence of X and Y. This means the
effect of Act. D does not depend on its concentration.
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Xvs.Y No effect (y1) Facilitation (y2) Inhibition (y3) Total
10−3 = x1 10 7 5 22
10−4 = x2 26 17 19 62
10−5 = x3 42 16 14 72
10−6 = x4 40 16 14 70
10−7 = x5 38 11 22 71
10−8 = x6 27 7 15 49
10−9 = x7 4 4 3 11
Total 187 78 92 357
Table 1: Data on antibiotic influence.
2. The test of homogeneity for every two rows shows similarity of all of them,
so there is a common distribution. The confidence intervals are:
p MIN AVG MAX
p0 0.4557 0.5238 0.5919
p+ 0.1622 0.2185 0.2748
p
−
0.1981 0.2577 0.3173
The results demonstrate a balanced effect of Act. D. on the linker his-
tones/DNA interactions in case without preliminary treatment of DNA with
antibiotic (so called “real competition assay”). The main table analyzed above
represents data from the experiment with histone H1. We have created some
additional tables with histone H5 (relative to H1) and with another antibiotic-
Netropsin possessing another mode for binding to the double helix of DNA: it
simply invades into the minor groove preferentially (if not only) in A-T reach
stretches of the polynucleotide chain.
Comparative analysis of all the results infers some points of use:
1. For histone H5 there exists again common distribution with somewhat dif-
ferent parameters:
p MIN AVG MAX
p0 0.0243 0.1509 0.2776
p+ 0.5141 0.6792 0.8444
p
−
0.0370 0.1698 0.3027
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2. For Netropsin we obtained dependency in χ2 test. It means the behavior
of Netropsin depends on its concentration.
3. We also have the case of preliminary incubation of that antibiotic with
DNA. Here the resulting common distribution looks this way:
p MIN AVG MAX
p0 0.0663 0.1462 0.2260
p+ 0.5381 0.6462 0.7542
p
−
0.1160 0.2077 0.2993
This points out to strong facilitating effect of the antibiotic on the linker
histones/DNA interactions in the case with preliminary treatment of DNA
with the drug (competition assay).
4. Additional immunochemical assays and statistical inference.
Another type of experiments, based on ELISA (enzyme-linked immunosorbent as-
say) considers a hypothesis. Immunochemical methods are widely used in modern
molecular biology. Antibodies (or immunoglobulins) are series of highly relative
glycoproteins, produced in the organism as a result of the invasion of foreign
protein or some polysacharides (Abbas et al., 2000). Sensibility of the reaction
antigen – antibody is high enough to prove the presence, as well as the degree of
association of an antigen with its complementary antibody. Nucleic acids (DNA,
RNA) are not immunogens, but haptens, i.g. they are not able to challenge
antibodies themselves, but complexed with proteins they do (Desai andMarion,
2000). A terrible disease, named Systemic Lupus Erythematosus exists, for which
the presence of auto-antibodies against DNA and histone/DNA complexes is a
reliable marker in differential diagnosis (Moens et al., 1995, Takuichi et al, 1995,
Khalil at al., 1999). In spite of numerous investigations, the etiology of this
disease is still unknown and usually the exact diagnosis has been pronounced
during the advanced stage of the disease. As far as there are data showing the
appearance of lupus-like syndrome and presence of anti-DNA antibodies after
long-term treatment with anticancer antibiotics, scientists tend to accept the hy-
pothesis that the reason for producing such pathogenic auto-antibodies could be
conformational-modified DNAs, which in complex with circulating proteins, or
even peptides, are identified as a foreign body in the organism (Desai and Marion,
2000). Our initial experiments aiming to prove such antibodies, treating with an-
tibiotics rats with Guerin ascyte tumour induced are in process. As a referent a
344 J. Yaneva, N. Daskalova, N. Yanev
polyclonal immune rabbit antiserum with antibodies against total histone/DNA
complexes was produced (Zacharieva et al., 2004). Preparation of total histone
includes linker histone H1 and core histones hH2A, hH2B, hH3, hH4 (Zlatanova
and Yaneva, 1991a). The spectrum and the titer of the antibodies produced were
firstly demonstrated with dot-immunobinding assay and then confirmed using
ELISA (enzyme-linked immunosorbent assay). The results showed that the most
part of antibodies in that polyclonal antiserum was against plasmid DNA com-
pared with that to total histone and to complexes itself. We have obtained the
following preliminary data – table 2.
pr.AG DNA Total h t.h./DNA
1 0.224 0.189 0.182
2 0.175 0.168 0.194
3 0.115 0.060 0.078
4 0.212 0.193 0.166
5 0.233 0.193 0.211
6 0.178 0.162 0.189
7 0.183 0.127 0.176
8 0.168 0.138 0.133
9 0.078 0.042 0.050
10 0.209 0.163 0.181
11 0.238 0.184 0.157
12 0.199 0.171 0.156
Table 2: Here every row contains the indications (a value for unspecific binding with
non-immune serum c=0.127 was subtracted from every single value of the ELISA-reader):
for pure DNA antigen, pure histone H1 and histone/DNA complexes in 12 independent
repetitions of the experiment.
Assumption is made that the first column (antigen pure DNA) differs from the
other two. To confirm this, tests of Willcockson and of signs were performed and
they showed that distribution of first column differs from the other two, which are
similar (confidence level α = 0.05). A drawing of empirical distribution functions
illustrates distinction between case of pure DNA and the other two (Figure 4).
Linker Histones/DNA Interactions 345
Figure 4: Empirical distribution functions.
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